Table 2. Mild symptoms and adverse effects (AE).
Mild symptoms (self-reported) | n | % | Mild symptoms (observed) | n | % | |
---|---|---|---|---|---|---|
Sleep Disturbance | 169 | 14.94 | Dizziness | 2 | 0.14 | |
Fatigue | 155 | 13.70 | Eczema | 2 | 0.14 | |
Dry Mouth | 100 | 8.84 | Bleeding gums | 1 | 0.07 | |
Back Pain | 84 | 7.43 | Hyperventilation | 1 | 0.07 | |
Hunger | 77 | 6.81 | Outbreak of infection | 1 | 0.07 | |
Bad Breath | 61 | 5.39 | Pleuropneumonia | 1 | 0.07 | |
Headache | 61 | 5.39 | Tetany | 1 | 0.07 | |
Muscle Pain | 49 | 4.33 | Visual disorder | 1 | 0.07 | |
Abdominal Bloating | 47 | 4.16 | ||||
Diarrhoea | 38 | 3.36 | ||||
Sensitivity to Cold | 33 | 2.92 | AE | n | % | |
Cravings | 29 | 2.56 | Cardiac arrhythmia | 3 | 0.21 | |
Vertigo | 28 | 2.48 | Hyponatremia | 3 | 0.21 | |
Blurred Vision | 23 | 2.03 | Hospitalisation | 2 | 0.14 | |
Restless Legs | 23 | 2.03 | Hypoglycaemia | 2 | 0.14 | |
Skin Rash | 19 | 1.68 | Hypokalaemia | 1 | 0.07 | |
Nausea | 13 | 1.15 | Gout | 1 | 0.07 | |
Palpitation | 13 | 1.15 | Vomiting | 1 | 0.07 | |
Dyspepsia | 12 | 1.06 | Spasmodic abdominal pain | 1 | 0.07 | |
Muscular cramp | 4 | 0.35 |
Out of the total of 1422 a group of 1311 subjects completed and returned the daily questionnaire to self-record mild symptoms. In contrast to the observed symptoms and AE, self-reported mild symptoms were recorded if a particular symptom was experienced by the same person more than 3 times during the fasting period. The observed symptoms and AE were documented during the daily nurse visit and/or the medical visit for all subjects. The same subject could mention more than one symptom or AE.